Vittoria Biotherapeutics is committed to unlocking the promise of cell therapies while addressing their inherent challenges by strengthening efficacy, improving safety, and broadening therapeutic applicability for patients with difficult-to-treat diseases.

Penn Medicine Co-Investment Program

Agent Capital

SV Health Investors

Tellus BioVentures

Vittoria Biotherapeutics, Inc.

Adaptimmune is a biotechnology company specializing in the development of T-cell therapies for cancer treatment.

Adaptimmune

Medigene is a biotechnology company engaged in the development of personalized T-cell immunotherapies for the treatment of cancer.

Medigene

Immatics is a clinical-stage biopharmaceutical company focused on the development of T-cell receptor-based immunotherapies for cancer treatment.

Immatics

Vittoria Biotherapeutics

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 7, 2024 2:57 PM	21c4baaa
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 7, 2024 2:57 PM	87aa725a
company summary	general
signals	general	Mar 7, 2024 2:57 PM	7acf1d14
crunchbase trigger	general	Nov 13, 2024 4:02 PM	eee85894
crunchbase profile	general
li profile	general	Mar 7, 2024 2:57 PM	b9636d32
translate crunchbase fundingrounds	general
peers	general	Mar 7, 2024 2:57 PM	b812c95e
news basic	general	Mar 7, 2024 2:57 PM	91c8557e
bundesanzeiger	filings	Mar 7, 2024 2:57 PM	b92b546f
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:VITTORIABIO

Vittoria Biotherapeutics